RT Journal Article
SR Electronic
T1 CT-based Rapid Triage of COVID-19 Patients: Risk Prediction and Progression Estimation of ICU Admission, Mechanical Ventilation, and Death of Hospitalized Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.04.20225797
DO 10.1101/2020.11.04.20225797
A1 Xu, Qinmei
A1 Zhan, Xianghao
A1 Zhou, Zhen
A1 Li, Yiheng
A1 Xie, Peiyi
A1 Zhang, Shu
A1 Li, Xiuli
A1 Yu, Yizhou
A1 Zhou, Changsheng
A1 Zhang, Longjiang
A1 Gevaert, Olivier
A1 Lu, Guangming
YR 2020
UL http://medrxiv.org/content/early/2020/11/06/2020.11.04.20225797.abstract
AB The wave of COVID-19 continues to overwhelm the medical resources, especially the stressed intensive care unit (ICU) capacity and the shortage of mechanical ventilation (MV). Here we performed CT-based analysis combined with electronic health records and clinical laboratory results on Cohort 1 (n = 1662 from 17 hospitals) with prognostic estimation for the rapid stratification of PCR confirmed COVID-19 patients. These models, validated on Cohort 2 (n = 700) and Cohort 3 (n = 662) constructed from 9 external hospitals, achieved satisfying performance for predicting ICU, MV and death of COVID-19 patients (AUROC 0.916, 0.919 and 0.853), even on events happened two days later after admission (AUROC 0.919, 0.943 and 0.856). Both clinical and image features showed complementary roles in events prediction and provided accurate estimates to the time of progression (p<.001). Our findings are valuable for delivering timely treatment and optimizing the use of medical resources in the pandemic of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the National Basic Research Program (973 Program) (grants No. 2014CB744504 to Guangming Lu) and by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB https://www.nibib.nih.gov/), R01 EB020527 and R56 EB020527 to OG.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study protocol was approved by the institutional review board of Jinling Hospital, Nanjing University School of Medicine (2020NZKY-005-02).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author (G.M.L.). The data with participant privacy/consent are not publicly available due to hospital regulation restrictions.